SAN FRANCISCO/BENGALURU (Reuters) – Twitter Inc (TWTR.N) posted worse-than-expected quarterly revenue and profit on Thursday, plagued by unusually low demand over the summer and technical issues that hurt its advertising, sending its shares down about 19%. Chief Financial Officer Ned Segal said the company’s ad platform encountered bugs, or glitches, that hindered its ability to
0 Comments
SYDNEY (Reuters) – Asian shares pulled ahead on Thursday with corporate earnings buffeting trading as investors remained anxious about the business impact of the Sino-U.S. trade war while Brexit uncertainties kept overall sentiment in check. FILE PHOTO: Passersby are reflected on a screen displaying graphs of market indices outside a brokerage in Tokyo, Japan, August
0 Comments
WASHINGTON (Reuters) – Republican lawmakers, encouraged by President Donald Trump to get tougher in fighting Democrats’ attempts to impeach him, on Wednesday disrupted the U.S. House of Representatives impeachment inquiry and prevented a Pentagon official from testifying. The Republicans stormed into a hearing room where Laura Cooper, the U.S. defense official who oversees Ukraine and
0 Comments
FILE PHOTO: A bottle of Zantac heartburn drug is seen in this picture illustration taken October 1, 2019. REUTERS/Brendan McDermid/Illustration/File Photo (Reuters) – The U.S. Food and Drug Administration said on Wednesday that alternatives to popular heartburn drug Zantac and its generic versions, known chemically as ranitidine, have not been found to contain the probable
0 Comments